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mortality: a systematic review
Lynne Rush1*, Gerry McCartney2, David Walsh3 and Daniel MacKay4Abstract
Background: All-cause mortality in the population < 65 years is 30% higher in Glasgow than in equally deprived
Liverpool and Manchester. We investigated a hypothesis that low vitamin D in this population may be associated
with premature mortality via a systematic review and meta-analysis.
Methods: Medline, EMBASE, Web of Science, the Cochrane Library and grey literature sources were searched until
February 2012 for relevant studies. Summary statistics were combined in an age-stratified meta-analysis.
Results: Nine studies were included in the meta-analysis, representing 24,297 participants, 5,324 of whom died
during follow-up. The pooled hazard ratio for low compared to high vitamin D demonstrated a significant inverse
association (HR 1.19, 95% CI 1.12-1.27) between vitamin D levels and all-cause mortality after adjustment for
available confounders. In an age-stratified meta-analysis, the hazard ratio for older participants was 1.25 (95% CI
1.14-1.36) and for younger participants 1.12 (95% CI 1.01-1.24).
Conclusions: Low vitamin D status is inversely associated with all-cause mortality but the risk is higher amongst
older individuals and the relationship is prone to residual confounding. Further studies investigating the association
between vitamin D deficiency and all-cause mortality in younger adults with adjustment for all important
confounders (or using randomised trials of supplementation) are required to clarify this relationship.
Keywords: Vitamin D, 25OHD, Premature mortality, Systematic review, Meta-analysisBackground
The extent to which vitamin D deficiency may be im-
portant in explaining morbidity and mortality has re-
cently been a focus for research. The importance of
vitamin D for bone health and the prevention of rickets
is well-established; however, observational data suggest
that low levels are also associated with increased inci-
dence of chronic diseases including cardiovascular dis-
ease, cancer, type II diabetes and multiple sclerosis [1-8].
Four meta-analyses of observational studies have also
found an association with increased all-cause mortality
[9-12]. Most of the populations in the included studies
were elderly, limiting applicability to the wider popula-
tion. It is also possible that the associations between
vitamin D and mortality seen in observational studies
are due to confounding with, for example, obesity or re-
duced physical activity causing both reduced vitamin D* Correspondence: lynne.rush@nhs.net
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reproduction in any medium, provided the orand negative health outcomes. In addition, observational
associations may be due to reverse causality, whereby
vitamin D is reduced as a consequence of disease
processes. Those randomised controlled trials of vitamin
D supplementation that are available are largely confined
to elderly populations with pre-existing morbidity, for ex-
ample, following hip fracture and are therefore not general-
isable to either younger or pre-morbid populations.
The potential for vitamin D deficiency to explain
higher mortality, and in particular premature mortality,
is particularly relevant in Scotland. Vitamin D deficiency
has been postulated as one of many explanations for the
‘excess’ mortality (that is, the higher levels of mortality
not explained in terms of socio-economic circumstances)
seen in Scotland, particularly in Glasgow, compared to the
rest of the UK [13-18]. The vitamin D hypothesis is sup-
ported by evidence that deficiency is higher in Scotland
than in the rest of the UK and the links in observational
studies between low vitamin D levels and all age mortality
and various chronic diseases [19].d. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Liverpool and Manchester, three cities with comparable
histories of deindustrialisation, and with strikingly simi-
lar socio-economic profiles [20]. After adjustment for
any remaining differences in levels of area deprivation,
all-cause mortality was found to be 15% higher in
Glasgow. Premature mortality (defined as deaths under
65 years) was 30% higher, and higher still for ages 15–
45 years. Further evidence regarding the link between
vitamin D deficiency and premature mortality is there-
fore required to evaluate whether the relatively high
Scottish mortality rates may be in part explained by vita-
min D deficiency.
This study aims to establish whether there is evidence
of an association between vitamin D deficiency and pre-
mature mortality, and the potential for any association
to be due to confounding.
Methods
The systematic review was conducted according to the
guidelines set out in the PRISMA statement [21].
Inclusion criteria
Studies in all settings and countries and involving both
male and female participants were included. Although
the primary association of interest was the association
between vitamin D and premature mortality, no upper
age limit was specified in order that patterns of associ-
ation at different ages could be identified. As the associ-
ation of interest was between vitamin D and mortality in
the general population, studies in which participants
were selected on the basis of pre-existing illness were
excluded. No restrictions were imposed for language,
year of publication or duration of follow-up.
Randomised controlled studies, non-randomised con-
trolled studies and cohort studies were included if they
involved an appropriate population. Case–control, cross-
sectional, ecological and case series studies were ex-
cluded, as they were considered to be at high risk of
confounding. Studies which investigated the effects of
vitamin D supplementation but which did not report
vitamin D status, or which estimated vitamin D status
on the basis of reported sun exposure or dietary intake
were excluded, as these were felt likely to lack precision.
Only studies that reported on all-cause mortality were
included.
Search strategy
Ovid Medline, Embase, Web of Science and the
Cochrane library were searched until February 2012.
The search terms used are detailed in Additional file 1.
Duplicate results were removed using the reference
management system Refworks. Screening of search re-
sults on title, or title and abstract, were carried outindependently by two reviewers. Disagreements were re-
solved through discussion and reference to the inclusion
criteria. Where articles were available only in abstract
form, supplementary data were requested from the au-
thors by email.
In order to identify relevant grey literature, the same
search terms were entered in the British Library online
catalogue and the internet search engines Google and
Google scholar were searched using the terms “vitamin
D” and “mortality”. The first 400 results from each were
also screened independently by two reviewers.
Reference lists of relevant systematic reviews identified
were screened for additional articles. The journals in
which the main relevant studies were published were
hand searched for previously unidentified articles
(Additional file 1). Authors of the studies taken forward
for critical appraisal and of the main relevant systematic
reviews were contacted with requests for relevant un-
published data or research in progress.
For studies published in languages other than English,
an internet translation tool was used to facilitate screen-
ing. If further information was required, the author was
contacted with a request for translated material.
Critical appraisal
Studies which met the inclusion criteria were assessed
for bias and confounding using questions based on the
Critical Appraisal Skills Programme (CASP) tool for ap-
praisal of observational studies (Additional file 1) [22].
Critical appraisal was carried out independently by
two of three reviewers, blinded to the other’s results.
Where the recruitment methods or response rates
within a study were unclear, the protocol for the original
cohort study was accessed. Disagreements between the
reviewers were resolved by discussion.
Data extraction
The following data were extracted from the included
studies by one reviewer and checked by another and
recorded in a Microsoft Excel spreadsheet: year of publi-
cation; summary mortality measure and confidence
interval; study size; method used to quantify vitamin D
levels; average age of participants; average follow-up
time; mean 25OHD level within each category or quan-
tile; and the confounding variables adjusted for. Through
a combination of prior awareness and insight gained
while undertaking the literature review, we considered
that the most likely confounders in the relationship be-
tween 25OHD levels and all-cause mortality were age,
sex, ethnicity, season of measurement, smoking, physical
activity, BMI, socioeconomic status, chronic disease, use
of vitamin supplements and sun exposure. ‘Average’
follow-up time and age refers to the mean or median
values, as reported in the individual studies.
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As an initial descriptive analysis, we produced a
scatterplot of log hazard ratio for all-cause mortality
against the average 25OHD in each quantile or category
for each of the included studies. We then performed a
meta-analysis using Stata (v12.0) using a random effects
model to account for heterogeneity between studies. In
the included studies, hazard ratios for all-cause mortality
for different quantiles or categories of vitamin D were
compared to a reference group. The participants within
each category were treated as distinct study populations
and the hazard ratios entered separately into the meta-
analysis.
A meta-analysis of the log transformations of the haz-
ard ratios was carried out using the ‘metan’ command
within Stata [23,24]. Separate forest plots summarising
the effect sizes of the individual studies and the pooled
effect sizes were obtained for the adjusted and un-
adjusted hazard ratios. In order to assess whether the as-
sociation between 25OHD level and mortality was
different in older versus younger participants, a stratified
analysis was performed, producing separate pooled effect
sizes for studies with an average participant age under
and over 65 years. Previous research has suggested that
follow-up time may influence the ability to detect signifi-
cant effects between 25OHD and mortality, therefore a
stratified analysis was performed to assess the influence
of follow-up time on the effect size [25].
The standard error of the log hazard ratios was
calculated and a funnel plot was produced using the
‘metafunnel’ command to assess for publication bias
[26]. A more formal investigation of funnel plot
asymmetry due to small study effects was also
performed using Egger’s linear regression method, gen-
erated by the ‘metabias’ command to test whether there
was a linear association between the effect size and its
standard error [27].Results
Search results
The PRISMA flow chart in Figure 1 summarises the re-
sults of the search process. The authors of the 11 articles
that were available in abstract form only were contacted
via email with a request for further information. One au-
thor could not be reached (mail undelivered). Of a fur-
ther 11 authors contacted, nine responded. Four of these
authors provided full-text versions of their papers, yield-
ing a further three articles suitable for critical appraisal.
Two articles were unobtainable either in abstract or full-
text format. The articles that were unobtainable or
available as abstracts only are listed in Additional file 1.
The breakdown of reasons for exclusion of full-text ar-
ticles is detailed in Additional file 1. Of the 34 studiesthat were critically appraised, 23 were excluded.
Additional file 1 lists the reasons for exclusion.Characteristics of studies included in the
systematic review
Eleven studies were included in the review. Of these,
nine were suitable for inclusion in the meta-analysis,
containing 24,297 participants. 5,324 deaths occurred
during follow-up. Table 1 lists the characteristics of the
included studies.
The majority of the included studies reported mortal-
ity outcomes in the form of relative hazard ratios for dif-
ferent quantiles or categories of 25OHD. Johansson et
al’s study did not fully report mortality outcomes or con-
fidence intervals for different 25OHD quantiles while
the study by Melamed et al. presented the outcome as a
mortality rate ratio, of which was incompatible with the
hazard ratios used in the other studies [33,34]. These
studies are included in the narrative review but were ex-
cluded from the meta-analysis. In all but one of the
other studies the quantile or category containing the
highest 25OHD levels were used as the reference group;
instead, Michaelsson et al. used the participants with
25OHD in the middle 10-90th centiles as a reference
group [35]. The hazard ratios for the participants in the
0-5th and 0-10th centiles were entered into the meta-
analysis but the hazard ratios for those in the upper cat-
egories (90th-100th centile and 95th-100th centile) were
omitted. This ensured that all the hazard ratios entered
into the meta-analysis measured effects in the same dir-
ection, i.e. comparison of mortality outcomes in individ-
uals with lower compared to higher vitamin D levels
within the same study population. Bates et al’s study
reported the hazard ratio for all-cause mortality for a
continuous increase in 25OHD only; Chris Bates and his
colleague Gita Mishra kindly recalculated the hazard ra-
tios for quartiles of 25OHD in order that this study
could be included in the meta-analysis [28,39].
Two studies (Melamed and Ginde) presented data
from the same cohort study. Ginde’s study was included
in the meta-analysis, Melamed’s study having been
already excluded [30].Relationship between 25OHD level and all-cause mortality
Significantly raised hazard ratios for all-cause mortality
were seen at least in the lowest category or quantile of
25OHD compared to the reference category in all of the
studies. However, in the fully adjusted models, three of
the nine studies (Ford, Jia and Visser) did not find evi-
dence of a significant association between 25OHD and
all-cause mortality. No consistent differences were noted
in the confounding factors adjusted for by these studies
compared to the others.
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tality in the individual studies are displayed visually in
the scatterplot matrix in Figure 2.
The fact that all but one of the studies used the
highest category or quantile as the reference category
suggests an a priori assumption that the true relation-
ship between 25OHD and all-cause mortality is inverse;
however, such a pattern is not seen consistently across
the studies. In fact, a non-linear relationship is seen in
six of the nine studies. In four of these studies, all-
cause mortality actually appears to be reduced in cat-
egories where 25OHD is lower than in the reference
group (Ford, Hutchinson (smokers), Jia and Visser).
Michaelsson et al’s study is the only one in which all-
cause mortality at higher levels of 25OHD is compared
to more moderate levels. In this study, mortality is
significantly elevated at both below the 10th and above
the 95th centiles, with the 10-90th centiles as the
reference group.Figure 1 PRISMA 2009 Flow Diagram.No consistent pattern was seen between the studies
containing younger participants compared to those with
an older population.
Synthesis of results
Using the unadjusted hazard ratios, the overall effect size
for all-cause mortality for the lowest quantile or category
of 25OHD compared to the reference category within
each study was 1.42 (95% confidence interval 1.30-1.55).
In the age-stratified analysis, the pooled effect size for
participants under 65 years was 1.30 (95% confidence
interval 1.16-1.46) and for those aged over 65 years was
1.50 (95% confidence interval 1.32-1.71) (Additional
file 1). The overall effect size for all-cause mortality
using the adjusted hazard ratios was 1.19 (95% confi-
dence interval 1.12-1.27). Stratified by age, the overall ef-
fect size was 1.12 (95% confidence interval 1.01-1.24) for
studies with participants with mean age under 65 years
and 1.25 (95% confidence interval 1.14-1.36) for those
Table 1 Characteristics of the studies included in the systematic reviews
Study Year Country Design Population Sample size Average age (years)a Response rate% Overall
representativeness
of populationb
Average follow-
up duration
(years) a
Bates [28] 2011 UK Prospective
cohort
Men and women aged ≥65y 1,054 Males 75.8 Females 77.3 36 Fair 13.5
Ford [29] 2011 USA Prospective
cohort
Men and women aged over 20
across USA
7,531 Mean 45–46 (by ascending
25OHD concentration)
80 (2001/2
sample), 76
(2003/4 sample)
Excellent Median 3.8
Ginde [30] 2009 USA Prospective
cohort
Men and women aged over 65
across USA
3,408 Mean 72–76 (by ascending
25OHD category)
60.1 Good Median 7.3
Hutchinson
[31]
2010 Norway Prospective
cohort
Men and women over age of 25
living in city of Tromso
Smokers – 2,410
Non-smokers –
4,751
Smokers – mean 57–58 (by
ascending 25OHD quartile).
78 Good Mean Smokers –
11.4 Non-
smokers 11.8
Non-smokers mean 59–61 (by
ascending 25OHD quartile)
Jia [32] 2007 UK Prospective
cohort
Men and women over age of 75
living in city of Aberdeen
398 Median 80 Men 25 Women
17
Fair Median 5.95
Johansson
[33]
2011 Sweden Prospective
cohort
Men aged 70–81 years living in
cities of Gothenburg, Malmo and
Uppsala
3,014 Mean 75 45 Fair 6
Melamed
[34]
2008 USA Prospective
cohort
Men and women aged over 20
across USA
13,331 Mean 41.0-46.7 (by 25OHD
quartile)
67.7 Excellent Median 8.7
Michaelsson
[35]
2010 Sweden Prospective
cohort
Men born during 1920–4 living
in city of Uppsala
1,194 Mean 71 73 Good Median 12.7
Semba [36] 2010 Italy Prospective
cohort
Men and women over 65 living
in Tuscany
1,155 Median 71–78 (by ascending
25OHD quartile)
90.3 Good 6.5
Virtanen [37] 2011 Finland Prospective
cohort
Middle aged men and women in
Eastern Finland
1,136 Mean 61–62 (by ascending
25OHD tertile)
Men – 85.6
Women – 78.4
Good 9.1
Visser [38] 2006 Netherlands Prospective
cohort
Men and women aged over 65
living in city of Amsterdam
1,260 No average given, all over 65,
recalculated as mean 70.2-78.5
by category
81.7 Good 6
a – mean or median specified where reported in original study.
b - based on recruitment method and response rate.
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http://www.biomedcentral.com/1471-2458/13/679over 65 years (Figure 3). No consistent pattern was seen
for effect size according to duration of follow-up using the
unadjusted or adjusted hazard ratios (Additional file 1).Publication bias
The funnel plot of the logHRs against their standard errors
can be seen in Additional file 1. Asymmetry towards the
lower left region of the funnel plot suggests a lack of smaller
studies with negative effects (i.e. those that do not show a
reduction in all-cause mortality with increasing 25OHD
levels). This is supported by the results of Egger’s test, which
gives a p value of 0.04 suggesting that small study publica-
tion bias cannot be excluded. Note that only three studies
contained non-elderly participants which makes it difficult
to assess for publication bias in this subgroup.
In order to identify which factors within the studies
were associated with a larger effect size, a meta-
regression analysis was performed. Methodology and re-
sults are available as webmaterials; of note, increasing
age was associated with a larger hazard ratio though did
not remain significant after adjustment for multiple1
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Figure 2 Scatterplot matrix of relationship between 25OHD categorycomparisons. In addition, the studies were highly
variable in their adjustment for potential confounders.
The impact of adjustment for the various confounders
on the overall effect size was also investigated via
metaregression; adjustment for socioeconomic status
and use of vitamin supplements were associated with a
significant increase in the overall hazard ratio but did
not remain significant in the multivariate analysis.Discussion
Main finding of this study
The meta-analysis of 29 hazard ratios from nine studies
demonstrates a statistically significant increase in the
risk of all-cause mortality in individuals with low versus
high 25OHD (HR 1.42, 95% confidence interval 1.30-
1.55). After maximal adjustment for confounding
factors, the hazard ratio was attenuated but remained
significant (HR 1.19, 95% confidence interval 1.12-1.27).
In the age-stratified meta-analysis, the risk of all-cause
mortality was significantly increased in both older (HR
1.25, 95% confidence interval 1.14-1.36) and, to a lesser70 80 90 100
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Figure 3 Forest plot displaying pooled effect of fully adjusted hazard ratios, stratified by age category.
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interval 1.01-1.24).
What is already known on this topic
The findings of this meta-analysis are consistent with pre-
vious systematic reviews that identified an inverse associ-
ation between 25OHD levels and mortality [9-12]. As in
the review by Zittermann et al., this relationship was not
observed at all concentrations and there appeared to be
no consistent pattern regarding at which concentrations
mortality was highest and lowest. For example, two of the
studies showed increased mortality at quartiles 1 and 3,
but not at quartile 2, suggesting non-linearity in the rela-
tionship. Only the study by Michaelsson et al. usedparticipants with 25OHD levels in the mid-range as a ref-
erence group, and in this study a U-shaped association
between 25OHD level and mortality was observed [35].
What this study adds
As far as we are aware, this is the only systematic review
and meta-analysis that has specifically investigated
whether the apparent association between low vitamin D
status and all-cause mortality is age-dependent. We
performed a comprehensive search strategy including an
extensive grey literature search, ensuring that all relevant
information should have been identified. We adhered to
strict inclusion criteria which ensured that only studies
that were representative of the general population were
Rush et al. BMC Public Health 2013, 13:679 Page 8 of 9
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findings.
Limitations of this study
Several limitations of the review are acknowledged. Few
studies provided data for individuals aged less than
65 years and the results are based on aggregate data.
Availability of individual level data would have allowed
stratification of mortality outcomes by narrower age
bands. The possibility of publication bias is also ac-
knowledged (Additional file 1), although the funnel plot
suggests that the unpublished studies are likely to be
those in younger adults which do not support an inverse
relationship between 25OHD level and mortality and in-
clusion of these studies would therefore not alter the
conclusions of the meta-analysis.
All of the included studies were observational in de-
sign and thus have limited capacity to demonstrate
causal associations between vitamin D levels and all-
cause mortality, and do not inform on the question of
whether a change in vitamin D (e.g. through supplemen-
tation) changes mortality outcomes. None of the in-
cluded studies adjusted for all important confounding
factors; for example, four of the 11 included studies
made no adjustment for socioeconomic status making
residual confounding in the association between low
vitamin D and all-cause mortality likely.
Conclusions
In this systematic review and meta-analysis, we sought
to evaluate evidence of the association between vitamin
D and premature mortality. Although a significant in-
crease in all-cause mortality was found in study partici-
pants of all ages with low compared to higher 25OHD
levels, the pooled effect size was lower for studies with
participants with an average age of less than 65 years
compared to the studies containing older participants. In
the multivariate meta-regression analysis, increasing age
was associated with a statistically significant increase in
the predicted hazard ratio. Many of the included studies
failed to adjust for important confounding factors such as
socioeconomic status which makes residual confounding in
the relationship likely. At present, there is insufficient data
to conclude that there is an inverse association between
low vitamin D status and overall mortality in younger
adults. Further observational studies using younger partici-
pants and with adjustment for all important confounders
(or alternatively, using randomised trials of supplementa-
tion) are required to clarify this relationship.
The nature of Scotland’s higher levels of premature
mortality (compared to elsewhere in the UK) must also
be considered when attempting to draw conclusions
about the potential contribution of vitamin D deficiency.
Although cardiovascular disease and cancer remainmajor contributors to Glasgow’s higher mortality relative
to Liverpool and Manchester, the majority of the ‘excess’
deaths under the age of 65 years are related to alcohol
and drugs, suicide and external causes (which include
violence and accidents) [20]. Increasing recognition of
the effects of vitamin D on cellular processes have gen-
erated many hypotheses regarding how deficiency may
be implicated in the pathogenesis of cardiovascular dis-
ease, cancer and other conditions. It seems less likely
however that a causal association between 25OHD levels
and road traffic accidents or drug-related deaths could
be considered plausible.
Additional file
Additional file 1: Webmaterials [40-42].
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